Two years fol­low­ing US ap­proval, Japan's Sh­iono­gi wins EU green light for opi­oid con­sti­pa­tion drug

Near­ly two years af­ter win­ning US ap­proval for its opi­oid-in­duced con­sti­pa­tion drug, Japan’s Sh­iono­gi has se­cured the Eu­ro­pean nod for the treat­ment, naldeme­dine, in pa­tients …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER